Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ERIS LIFESCIENCES vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ERIS LIFESCIENCES GLENMARK PHARMA ERIS LIFESCIENCES/
GLENMARK PHARMA
 
P/E (TTM) x 51.2 -41.5 - View Chart
P/BV x 7.3 5.3 138.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ERIS LIFESCIENCES   GLENMARK PHARMA
EQUITY SHARE DATA
    ERIS LIFESCIENCES
Mar-24
GLENMARK PHARMA
Mar-24
ERIS LIFESCIENCES/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs971974 99.7%   
Low Rs565464 121.6%   
Sales per share (Unadj.) Rs147.7418.6 35.3%  
Earnings per share (Unadj.) Rs29.2-64.9 -45.0%  
Cash flow per share (Unadj.) Rs42.6-44.3 -96.3%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.3 0.0%  
Book value per share (Unadj.) Rs189.7277.5 68.4%  
Shares outstanding (eoy) m136.03282.19 48.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.21.7 302.6%   
Avg P/E ratio x26.3-11.1 -237.3%  
P/CF ratio (eoy) x18.0-16.3 -110.9%  
Price / Book Value ratio x4.02.6 156.1%  
Dividend payout %0-3.9 -0.0%   
Avg Mkt Cap Rs m104,470202,964 51.5%   
No. of employees `000NANA-   
Total wages/salary Rs m4,03828,681 14.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,091118,131 17.0%  
Other income Rs m2388,400 2.8%   
Total revenues Rs m20,330126,531 16.1%   
Gross profit Rs m6,7482,944 229.2%  
Depreciation Rs m1,8265,819 31.4%   
Interest Rs m8485,160 16.4%   
Profit before tax Rs m4,312365 1,181.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34218,673 1.8%   
Profit after tax Rs m3,971-18,309 -21.7%  
Gross profit margin %33.62.5 1,347.9%  
Effective tax rate %7.95,116.7 0.2%   
Net profit margin %19.8-15.5 -127.5%  
BALANCE SHEET DATA
Current assets Rs m23,79074,281 32.0%   
Current liabilities Rs m26,09058,186 44.8%   
Net working cap to sales %-11.413.6 -84.0%  
Current ratio x0.91.3 71.4%  
Inventory Days Days1731 54.0%  
Debtors Days Days7757 133.5%  
Net fixed assets Rs m44,39858,808 75.5%   
Share capital Rs m136282 48.2%   
"Free" reserves Rs m25,67578,015 32.9%   
Net worth Rs m25,81178,297 33.0%   
Long term debt Rs m6,5450-   
Total assets Rs m68,188133,089 51.2%  
Interest coverage x6.11.1 568.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.30.9 33.2%   
Return on assets %7.1-9.9 -71.5%  
Return on equity %15.4-23.4 -65.8%  
Return on capital %15.97.1 226.0%  
Exports to sales %00-   
Imports to sales %0.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m23NA-   
Fx inflow Rs m032,207 0.0%   
Fx outflow Rs m2319,636 0.1%   
Net fx Rs m-2312,571 -0.2%   
CASH FLOW
From Operations Rs m4,860-2,654 -183.1%  
From Investments Rs m-18,54545,609 -40.7%  
From Financial Activity Rs m13,798-39,061 -35.3%  
Net Cashflow Rs m3822,152 17.8%  

Share Holding

Indian Promoters % 54.9 46.7 117.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 26.6 36.3 73.4%  
FIIs % 8.0 23.1 34.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 53.4 84.6%  
Shareholders   46,346 193,949 23.9%  
Pledged promoter(s) holding % 18.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ERIS LIFESCIENCES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ERIS LIFESCIENCES vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ERIS LIFESCIENCES vs Glenmark Pharma Share Price Performance

Period ERIS LIFESCIENCES Glenmark Pharma S&P BSE HEALTHCARE
1-Day 0.97% -0.37% 0.58%
1-Month 8.08% -13.27% -0.88%
1-Year 45.57% 88.02% 42.70%
3-Year CAGR 22.84% 46.01% 20.09%
5-Year CAGR 27.19% 33.55% 26.08%

* Compound Annual Growth Rate

Here are more details on the ERIS LIFESCIENCES share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ERIS LIFESCIENCES hold a 54.9% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ERIS LIFESCIENCES and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ERIS LIFESCIENCES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at -3.9%.

You may visit here to review the dividend history of ERIS LIFESCIENCES, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.